Curanex Pharmaceuticals Inc
CURX
$0.44
$0.037.48%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -464.70% | -210.94% | -326.40% | -1,727.98% | -- |
| Total Depreciation and Amortization | -- | -- | 1,522.22% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 70,400.00% | -- | 74,600.00% | -- |
| Change in Net Operating Assets | -3,586.64% | -75.47% | -24,333.33% | -1,713.37% | -- |
| Cash from Operations | -2,012.65% | -101.36% | -549.84% | -277,650.00% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | 13,233.33% | 6,566.67% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,139.34% | -100.00% | 386.99% | 811.72% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -100.00% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,073.91% | -43.04% | 538.90% | 773.93% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,189.47% | -171.36% | 502.14% | 3.76% | -- |